Iron chelator-Deferoxamine attenuated hemorrhagic transformation in a rat model of transient focal cerebral ischemia

XING Ying-qi,MENG Meng,WU Jiang
DOI: https://doi.org/10.19845/j.cnki.zfysjjbzz.2013.07.002
2013-01-01
Abstract:Objective To observe whether iron chelator-Deferoxamine(DFX) can attenuate hemorrhagic transformation in a rat model of transient focal cerebral ischemia.Methods We established the model by occlusion of middle cerebral artery with reperfusion.Ninety-eight model rats were randomly divided into two groups: DFX group and control group.We observed the mortality,hemorrhagic conversion rate,cerebral infarction volume,cerebral edema level,bleeding volume,blood-brain barrier permeability of the two groups.Results(1) After 2h of ischaemia and 2h of reperfusion,Evans-blue leakage of DFX group is less than that of control group(P < 0.01).(2) After 2h of ischaemia and 6h of reperfusion,the amount of bleeding in DFX group is less than that of control group(P < 0.05).(3) After 2h of ischaemia and 22h of reperfusion,the mortality of DFX group was significantly lower than that of control group(P < 0.05).(4) After 2h of ischaemia and 22h of reperfusion,the infarction volume of DFX group was obviously smaller than that of control group(P < 0.05).(5) After 2h of ischaemia and 22h of reperfusion,the brain swelling ratio of basal ganglia in DFX group is obviously less than that of control group(P < 0.05).Conclusion DFX can reduce the incidence of hemorrhagic transformation and the brain damage by protecting blood brain barrier.
What problem does this paper attempt to address?